In clinical practice, a JJ stent should only remain in place for 2–8 weeks, depending on the patient’s condition. Failure to ...

NEW YORK, May 19 (Reuters) - Johnson & Johnson said six-month study data showed its new experimental stent was better than Boston Scientific's Taxus at preventing re-growth of tissue within the tiny ...

ATLANTA, March 15 (Reuters) - Johnson & Johnson's Cypher drug-coated stent led to significantly fewer heart attacks, deaths and need for repeat procedures than Medtronic Inc's newer Endeavor stent ...

Johnson & Johnson intends to exit the drug-coated stent market by the end of this year-which could be good news for rivals like Fridley-based Medtronic, Inc., and Natick, Massachusetts-based Boston ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

A Johnson & Johnson (NYSE:JNJ) subsidiary allegedly issued a sham recall of its drug-eluting CoStar coronary stent and spiked a distribution deal with Biotronik AG that cost the German medical device ...

GAITHERSBURG, Md. (CBS.MW) -- A federal advisory panel voted late Tuesday in favor of a new Johnson & Johnson device that's expected to significantly improve heart-disease treatment. The Food and Drug ...

Wilmington, DE - A federal jury has awarded Johnson & Johnson $271 million in damages, to be paid by Medtronic Arterial Vascular Engineering (AVE), Inc, after the same US District Court jury's found ...